RESUMO
Magnetic hyperthermia - a potential cancer treatment in which superparamagnetic iron oxide nanoparticles (SPIONs) are made to resonantly respond to an alternating magnetic field (AMF) and thereby produce heat - is of significant current interest. We have previously shown that mesenchymal stem cells (MSCs) can be labeled with SPIONs with no effect on cell proliferation or survival and that within an hour of systemic administration, they migrate to and integrate into tumors in vivo. Here, we report on some longer term (up to 3 weeks) post-integration characteristics of magnetically labeled human MSCs in an immunocompromized mouse model. We initially assessed how the size and coating of SPIONs dictated the loading capacity and cellular heating of MSCs. Ferucarbotran(®) was the best of those tested, having the best like-for-like heating capability and being the only one to retain that capability after cell internalization. A mouse model was created by subcutaneous flank injection of a combination of 0.5 million Ferucarbotran-loaded MSCs and 1.0 million OVCAR-3 ovarian tumor cells. After 2 weeks, the tumors reached ~100 µL in volume and then entered a rapid growth phase over the third week to reach ~300 µL. In the control mice that received no AMF treatment, magnetic resonance imaging (MRI) data showed that the labeled MSCs were both incorporated into and retained within the tumors over the entire 3-week period. In the AMF-treated mice, heat increases of ~4°C were observed during the first application, after which MRI indicated a loss of negative contrast, suggesting that the MSCs had died and been cleared from the tumor. This post-AMF removal of cells was confirmed by histological examination and also by a reduced level of subsequent magnetic heating effect. Despite this evidence for an AMF-elicited response in the SPION-loaded MSCs, and in contrast to previous reports on tumor remission in immunocompetent mouse models, in this case, no significant differences were measured regarding the overall tumor size or growth characteristics. We discuss the implications of these results on the clinical delivery of hyperthermia therapy to tumors and on the possibility that a preferred therapeutic route may involve AMF as an adjuvant to an autologous immune response.
Assuntos
Dextranos/administração & dosagem , Hipertermia Induzida/métodos , Nanopartículas de Magnetita/uso terapêutico , Células-Tronco Mesenquimais/química , Neoplasias Experimentais/terapia , Animais , Meios de Contraste , Feminino , Humanos , Campos Magnéticos , Imageamento por Ressonância Magnética/métodos , Nanopartículas de Magnetita/administração & dosagem , Transplante de Células-Tronco Mesenquimais/métodos , Camundongos Nus , Neoplasias Experimentais/patologiaRESUMO
OBJECTIVE: To compare the diagnostic interpretation of traditional ventilation/perfusion (V/Q) planar images with that of planar-like images reprojected from single-photon emission computed tomography (SPECT) data sets. METHODS: Retrospective data from patients who had undergone both planar and SPECT imaging were used to generate anonymized reprojected planar images, which were compared with traditional planar V/Q images. Two consultants interpreted both sets of images for 81 patients following a proforma. We assessed the agreement in the final diagnosis between the two imaging methods and between the two clinicians. We also compared the number, nature, and localization of defects, as well as image quality. Finally, we compared the diagnosis made using planar methods with the original diagnosis made using SPECT. RESULTS: There was excellent agreement in diagnosis both between the two planar methods (κ=0.93) and between the two consultants (κ=0.91). Similar numbers of defects were detected, with fewer matched defects being reported in the reprojected group by one of the clinicians. Localization of defects and image quality were similar for the two imaging methods. Six additional pulmonary embolisms were diagnosed using SPECT data. CONCLUSION: We have shown that the performance of reprojected planars from SPECT V/Q was similar to that of traditional planars. These results have potential important implications for patient workflow in busy nuclear medicine departments, as well as for patient comfort.
Assuntos
Processamento de Imagem Assistida por Computador/métodos , Embolia Pulmonar/diagnóstico por imagem , Embolia Pulmonar/fisiopatologia , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Relação Ventilação-Perfusão , Humanos , Criptônio/farmacologia , Estudos Retrospectivos , Software , Relação Ventilação-Perfusão/efeitos dos fármacosRESUMO
Gadolinium-labelled nanocomplexes offer prospects for the development of real-time, non-invasive imaging strategies to visualise the location of gene delivery by MRI. In this study, targeted nanoparticle formulations were prepared comprising a cationic liposome (L) containing a Gd-chelated lipid at 10, 15 and 20% by weight of total lipid, a receptor-targeted, DNA-binding peptide (P) and plasmid DNA (D), which electrostatically self-assembled into LPD nanocomplexes. The LPD formulation containing the liposome with 15% Gd-chelated lipid displayed optimal peptide-targeted, transfection efficiency. MRI conspicuity peaked at 4h after incubation of the nanocomplexes with cells, suggesting enhancement by cellular uptake and trafficking. This was supported by time course confocal microscopy analysis of transfections with fluorescently-labelled LPD nanocomplexes. Gd-LPD nanocomplexes delivered to rat brains by convection-enhanced delivery were visible by MRI at 6 h, 24 h and 48 h after administration. Histological brain sections analysed by laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) confirmed that the MRI signal was associated with the distribution of Gd(3+) moieties and differentiated MRI signals due to haemorrhage. The transfected brain cells near the injection site appeared to be mostly microglial. This study shows the potential of Gd-LPD nanocomplexes for simultaneous delivery of contrast agents and genes for real-time monitoring of gene therapy in the brain.
Assuntos
Meios de Contraste/administração & dosagem , DNA/administração & dosagem , Gadolínio/administração & dosagem , Glicosiltransferases/administração & dosagem , Nanopartículas/administração & dosagem , Animais , Encéfalo/metabolismo , Linhagem Celular Tumoral , Meios de Contraste/química , Meios de Contraste/farmacocinética , DNA/química , Ácidos Graxos Monoinsaturados/química , Gadolínio/química , Gadolínio/farmacocinética , Glicosiltransferases/química , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Nanopartículas/química , Peptídeos , Fosfatidiletanolaminas/química , Compostos de Amônio Quaternário/química , Ratos , Ratos Wistar , Transfecção/métodosRESUMO
The success of cell therapies depends on the ability to deliver the cells to the site of injury. Targeted magnetic cell delivery is an emergent technique for localised cell transplantation therapy. The use of permanent magnets limits such a treatment to organs close to the body surface or an implanted magnetic source. A possible alternative method for magnetic cell delivery is magnetic resonance targeting (MRT), which uses magnetic field gradients inherent to all magnetic resonance imaging system, to steer ferromagnetic particles to their target region. In this study we have assessed the feasibility of such an approach for cell targeting, using a range of flow rates and different super paramagnetic iron oxide particles in a vascular bifurcation phantom. Using MRT we have demonstrated that 75% of labelled cells could be guided within the vascular bifurcation. Furthermore we have demonstrated the ability to image the labelled cells before and after magnetic targeting, which may enable interactive manipulation and assessment of the distribution of cellular therapy. This is the first demonstration of cellular MRT and these initial findings support the potential value of MRT for improved targeting of intravascular cell therapies.
Assuntos
Leucócitos Mononucleares/citologia , Imageamento por Ressonância Magnética/métodos , Sobrevivência Celular/efeitos dos fármacos , Meios de Cultura/farmacologia , Compostos Férricos/metabolismo , Humanos , Ferro/metabolismo , Leucócitos Mononucleares/efeitos dos fármacos , Modelos Biológicos , Coloração e RotulagemRESUMO
Superparamagnetic iron oxide nanoparticles (SPIONs) can substantially improve the sensitivity of magnetic resonance imaging (MRI). We propose that SPIONs could be used to target and image cancer cells if functionalized with recombinant single chain Fv antibody fragments (scFv). We tested our hypothesis by generating antibody-functionalized (abf) SPIONs using a scFv specific for carcinoembryonic antigen (CEA), an oncofoetal cell surface protein. SPIONs of different hydrodynamic diameter and surface chemistry were investigated and targeting was confirmed by ELISA, cellular iron uptake, confocal laser scanning microscopy (CLSM) and MRI. Results demonstrated that abf-SPIONs bound specifically to CEA-expressing human tumour cells, generating selective image contrast on MRI. In addition, we observed that the cellular interaction of the abf-SPIONs was influenced by hydrodynamic size and surface coating. The results indicate that abf-SPIONs have potential for cancer-specific MRI.
Assuntos
Neoplasias Colorretais/imunologia , Neoplasias Colorretais/patologia , Meios de Contraste/síntese química , Compostos Férricos , Separação Imunomagnética/métodos , Nanopartículas/química , Anticorpos de Cadeia Única , Linhagem Celular Tumoral , Sistemas de Liberação de Medicamentos/métodos , Compostos Férricos/química , Humanos , Aumento da Imagem/métodos , Nanopartículas/ultraestrutura , Proteínas Recombinantes , Anticorpos de Cadeia Única/químicaRESUMO
The ability of mesenchymal stem cells (MSC) to specifically home to tumors has suggested their potential use as a delivery vehicle for cancer therapeutics. MSC integration into tumors has been shown in animal models using histopathologic techniques after animal sacrifice. Tracking the delivery and engraftment of MSCs into human tumors will need in vivo imaging techniques. We hypothesized that labeling MSCs with iron oxide nanoparticles would enable in vivo tracking with magnetic resonance imaging (MRI). Human MSCs were labeled in vitro with superparamagnetic iron oxide nanoparticles, with no effect on differentiation potential, proliferation, survival, or migration of the cells. In initial experiments, we showed that as few as 1,000 MSCs carrying iron oxide nanoparticles can be detected by MRI one month after their coinjection with breast cancer cells that formed subcutaneous tumors. Subsequently, we show that i.v.- injected iron-labeled MSCs could be tracked in vivo to multiple lung metastases using MRI, observations that were confirmed histologically. This is the first study to use MRI to track MSCs to lung metastases in vivo. This technique has the potential to show MSC integration into human tumors, allowing early-phase clinical studies examining MSC homing in patients with metastatic tumors.
Assuntos
Materiais Biocompatíveis , Compostos Férricos , Neoplasias Pulmonares/patologia , Imageamento por Ressonância Magnética/métodos , Células-Tronco Mesenquimais/patologia , Nanopartículas , Animais , Materiais Biocompatíveis/administração & dosagem , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Compostos Férricos/administração & dosagem , Humanos , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/terapia , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/metabolismo , Camundongos , Camundongos Endogâmicos NOD , Camundongos SCID , Nanopartículas/administração & dosagem , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
OBJECTIVES: We sought to magnetically tag endothelial progenitor cells (EPCs) with a clinical agent and target them to a site of arterial injury using a magnetic device positioned outside the body. BACKGROUND: Circulating EPCs are involved in physiological processes such as vascular re-endothelialization and post-ischemic neovascularization. However, the success of cell therapies depends on the ability to deliver the cells to the site of injury. METHODS: Human EPCs were labeled with iron oxide superparamagnetic nanoparticles. Cell viability and differentiation were tested using flow cytometry. Following finite element modeling computer simulations and flow testing in vitro, angioplasty was performed on rat common carotid arteries to denude the endothelium and EPCs were administered with and without the presence of an external magnetic device for 12 min. RESULTS: Computer simulations indicated successful external magnetic cell targeting from a vessel with flow rate similar to a rat common carotid artery; correspondingly there was a 6-fold increase in cell capture in an in vitro flow system. Targeting enhanced cell retention at the site of injury by 5-fold at 24 h after implantation in vivo. CONCLUSIONS: Using an externally applied magnetic device, we have been able to enhance EPC localization at a site of common carotid artery injury. This technology could be more widely adapted to localize cells in other organs and may provide a useful tool for the systemic injection of cell therapies.
Assuntos
Lesões das Artérias Carótidas/cirurgia , Movimento Celular , Células Endoteliais/transplante , Óxido Ferroso-Férrico , Magnetismo , Coloração e Rotulagem/métodos , Transplante de Células-Tronco/métodos , Células-Tronco , Antígeno AC133 , Animais , Antígenos CD/análise , Apoptose , Lesões das Artérias Carótidas/patologia , Diferenciação Celular , Sobrevivência Celular , Células Cultivadas , Simulação por Computador , Dextranos , Modelos Animais de Doenças , Células Endoteliais/imunologia , Estudos de Viabilidade , Análise de Elementos Finitos , Citometria de Fluxo , Glicoproteínas/análise , Humanos , Nanopartículas de Magnetita , Masculino , Microscopia Confocal , Modelos Cardiovasculares , Nanopartículas , Peptídeos/análise , Projetos Piloto , Ratos , Ratos Sprague-Dawley , Células-Tronco/imunologia , Fatores de TempoRESUMO
Neurogenesis occurs at the subependymal zone (SEZ) of the adult brain. Neural progenitor cells give rise to neuroblasts, which migrate to the olfactory bulb (OB) via the rostral migratory stream (RMS). Development of methods capable of labelling and tracking these cells in vivo would be of great benefit to the understanding of neuroblast migration away from the SEZ under normal and pathological conditions. In this study, we demonstrate that endogenous neuroblasts can be labelled in vivo with an MRI contrast agent and that they can be visualised using MRI. We compared two labelling strategies: intraventricular injection of the ferumoxide Endorem, with or without the transfection agent protamine sulphate. Administration of Endorem alone resulted in its distribution outside of the ventricle and into the periventricular space after 48 h. In contrast, we observed that intraventricular injection of Endorem complexed to protamine sulphate--forming the FePro complex--is restricted to the ventricular walls after 48 h. The FePro complex successfully labelled Doublecortin(+) neuroblasts in vivo up to 28 days post-injection. FePro-labelled neuroblasts in the RMS could be visualised using MRI in vivo and ex vivo on a 2.35 T MRI system, and FePro-labelled cells were identified in the OB on a 9.4 T MRI system. This study demonstrates the feasibility of in vivo imaging of endogenous neuroblast migration using MRI.